WHO denies industry influence on pandemic response
The World Health Organization’s (WHO) response to the H1N1 pandemic was not improperly influenced by the pharmaceutical industry, Keiji Fukuda, special adviser on pandemic influenza to the WHO’s Director General, explained at a hearing held by the Council of Europe to address concerns over the WHO’s reaction to the pandemic. More...

Plan outlined for European generics
The Director General of the European Generic medicines Association (EGA) has reiterated the association’s Vision 2015 plan, which aims to create a globally competitive generic industry, increase patient access to affordable quality medicines and ensure sustainable healthcare in Europe. More...

Nanotechnology safety legislation introduced
Two US senators have introduced the Nanotechnology Safety Act of 2010, which would establish a programme within the FDA to assess the health and safety implications of nanotechnology in everyday products. More...

EMA outlines priorities for 2010–2015
The EMA has launched a public consultation on its Road Map to 2015 — a strategic vision that lays out the agency's priorities for the next 5 years. More...

Join PTE on LinkedIn!
Join Pharmaceutical Technology Europe's group on LinkedIn. More...

Product Profile Veltek   Veltek’s new sterile clean room wipes Veltek debuts new sterile clean room wipes, including the industry’s first sodium hypochlorite and hydrogen peroxide clean room wipes. Read more...